共 50 条
- [41] The patient's perspective on treatment with dacomitinib: patient-reported outcomes from the Phase III trial ARCHER 1050FUTURE ONCOLOGY, 2021, 17 (07) : 783 - 794Paty, JeanSandin, RickardReisman, ArleneWu, Yi-LongMigliorino, Maria RitaZhou, XiangdongCheng, YingLee, Ki HyeongNakagawa, KazuhikoNiho, SeijiCorral, JesusPluzanski, AdamLinke, RolfMeyers, OrenMok, Tony S.
- [42] Patient-Reported Outcomes of BMT CTN 1703: A Randomized Phase III Study for Gvhd Prophylaxis - a Quality of Life EvaluationBLOOD, 2023, 142Holtan, Shernan G.Martens, Michael J.Al Malki, Monzr M.Efebera, YvonneKitko, Carrie L.Reshef, RanRezvani, Andrew R.Shaffer, Brian C.Solh, Melhem M.Yao, Janny M.Runaas, LyndseyElmariah, HanyLarkin, Karilyn T.El Jurdi, Najla H.Gooptu, MahaswetaLoren, Alison W.Hall, Aric C.Alousi, AminJamy, OmerClark, William
- [43] The association of patient-reported symptoms and clinical and lung function parameters in patients with chronic obstructive pulmonary disease in stable phaseEXPERT REVIEW OF RESPIRATORY MEDICINE, 2020, 14 (06) : 637 - 643Vulpi, Maria RosariaLiotino, VitoDragonieri, SilvanoBuonamico, EnricoDimitri, MichelaCapozzolo, AlbertoResta, EmanuelaLozupone, MadiaPanza, FrancescoResta, Onofrio
- [44] Health-Related Quality of Life in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD): Impact of Lung Function on Patient-Reported Outcomes in a Randomized Phase III TrialARTHRITIS & RHEUMATOLOGY, 2019, 71Kreuter, MichaelHoffmnn-Vold, Anna MariaMatucci-Cerinic, MarcoSaketkoo, LesleyHighland, KristinWilson, HilaryAlves, MargaridaSchoof, NilsMaher, Toby
- [45] Upadacitinib improved patient-reported sleep in moderate-to-severe atopic dermatitis: results from a phase zb randomized, placebo controlled trialJOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2019, 33 : 60 - 61Reich, K.Liu, M.Calimlim, B.Teixeira, H. D.Silverberg, J. I.
- [46] Patient-reported Outcomes During Treatment in Patients with Moderate-to-severe Psoriasis: A Danish Nationwide StudyACTA DERMATO-VENEREOLOGICA, 2019, 99 (13) : 1224 - 1230Loft, Nikolai DyrbergEgeberg, AlexanderRasmussen, Mads KirchheinerBryld, Lars ErikGniadecki, RobertDam, Tomas NormanIversen, LarsSkov, Lone
- [47] Patient-reported outcomes with risankizumab versus fumaric acid esters in systemic therapy-naive patients with moderate to severe plaque psoriasis: a phase 3 clinical trialJOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2021, 35 (08) : 1686 - 1691Thaci, D.Soliman, A. M.Eyerich, K.Pinter, A.Sebastian, M.Unnebrink, K.Rubant, S.Williams, D. A.Weisenseel, P.
- [48] Dupilumab therapy provides clinically meaningful improvement in patient-reported outcomes (PROs): A phase IIb, randomized, placebo-controlled, clinical trial in adult patients with moderate to severe atopic dermatitis (AD)JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 75 (03) : 506 - 515Simpson, Eric L.Gadkari, AbhijitWorm, MargittaSoong, WeilyBlauvelt, AndrewEckert, LaurentWu, RichardArdeleanu, MariusGraham, Neil M. H.Pirozzi, GianlucaSutherland, E. RandMastey, Vera
- [49] APPROACH AND FEASIBILITY OF PATIENT-REPORTED OUTCOMES IN A PHASE III CLINICAL TRIAL FOR ADVANCED STAGE CLASSICAL HODGKIN LYMPHOMA IN CHILDREN AND ADOLESCENTSHAEMATOLOGICA, 2016, 101 : 37 - 37Castellino, S. M.Henderson, T. O.Keller, F.Kelly, K.Curtis, R.Conti, R. M.Parsons, S. K.
- [50] Prospective Observational Study of Clinical Outcomes After Intravenous Magnesium for Moderate and Severe Acute Asthma Exacerbations in ChildrenJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (05): : 1238 - 1246Arnold, Donald H.Gong, WuAntoon, James W.Bacharier, Leonard B.Stewart, Thomas G.Johnson, David P.Akers, Wendell S.Hartert, Tina, V